The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation

Vaccine
Y K OhJ A Swanson

Abstract

Macrophages can present exogenous antigen in association with MHC class I molecules. Indirect evidence indicates that antigens internalized by phagocytosis can enter cytoplasm before following the conventional MHC class I presentation pathway. However, little is known about how common such entry is, or to what extent it depends on the kind of particle ingested. This study reports quantitative and morphological characterization of antigen delivery from phagosomes into cytoplasm for MHC class I-restricted antigen presentation. Ovalbumin (OVA) was associated with polystyrene particles (PS), biodegradable poly-e-caprolactone particles (PCL), and sheep red blood cells (SRBC), and its delivery into macrophage cytoplasm, via phagocytosis was assessed with a T hybridoma assay for MHC class I-restricted presentation of OVA-derived peptides. Although direct introduction of antigen into cytoplasm by scrape-loading produced the most efficient presentation, comparable signals could be obtained after phagocytosis of PCL or PS. Phagocytosis of OVA-loaded SRBC, and OVA internalized by pinocytosis, did not deliver efficiently. MHC class I-restricted presentation of phagosome-derived OVA required cytoplasmic processing, as it was inhibited by pr...Continue Reading

References

Feb 1, 1990·The Journal of Experimental Medicine·F R Carbone, M J Bevan
Nov 1, 1989·The Journal of Experimental Medicine·E L Racoosin, J A Swanson
Dec 1, 1974·The Journal of Histochemistry and Cytochemistry : Official Journal of the Histochemistry Society·I W McLean, P K Nakane
Apr 1, 1984·The Journal of Cell Biology·P L McNeilD L Taylor
Nov 15, 1984·Analytical Biochemistry·S S Twining
Jun 1, 1993·Proceedings of the National Academy of Sciences of the United States of America·M Kovacsovics-BankowskiK L Rock
Feb 1, 1996·The Journal of Cell Biology·Y K Oh, J A Swanson
Mar 1, 1995·Trends in Cell Biology·C V Harding

❮ Previous
Next ❯

Citations

May 23, 2001·Archives of Biochemistry and Biophysics·S M EllerbroekM S Stack
Mar 1, 2000·Biochemical and Biophysical Research Communications·M A HayashiA C de Camargo
Jul 27, 2001·Journal of Immunological Methods·H T MaeckerL J Picker
Mar 14, 1998·Trends in Neurosciences·V W YongD R Edwards
Jul 17, 1999·Biochimica Et Biophysica Acta·N N Vettakkorumakankav, V S Ananthanarayanan
Mar 10, 2000·Biochimica Et Biophysica Acta·W Bode, R Huber
Apr 21, 1999·Molecular Microbiology·D E HigginsD A Portnoy
Dec 14, 2007·Molecular Biology of the Cell·Isabel María OlazabalFrancisco Sánchez-Madrid
Oct 11, 2005·Annual Review of Cell and Developmental Biology·Isabelle Jutras, Michel Desjardins
Feb 28, 2002·Annual Review of Immunology·Pierre GuermonprezSebastian Amigorena
Apr 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Niren MurthyJean M J Fréchet
Jan 14, 2004·The Journal of Cell Biology·Rebecca M HenryJoel A Swanson
Jun 24, 2008·Transfusion Medicine Reviews·Bernard Khor, Robert S Makar
Sep 27, 2005·Immunological Reviews·Kenneth L Rock, Lianjun Shen
Oct 30, 2010·Immunity·Margaret A Liu
Apr 25, 2008·Current Protocols in Immunology·C V Harding
May 29, 1999·Brazilian Journal of Medical and Biological Research = Revista Brasileira De Pesquisas Médicas E Biológicas·E Cunha-Neto
Feb 13, 2019·Frontiers in Immunology·Marine Gros, Sebastian Amigorena
Nov 6, 2007·The Journal of Immunology : Official Journal of the American Association of Immunologists·Zoran V PopovicHermann-Josef Gröne
Feb 10, 2010·Current Protocols in Immunology·Clifford V Harding, Lakshmi Ramachandra

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bioremediation (ASM)

Bioremediation is the treatment and removal of harmful pollutants or contaminants through the use of microorganisms. Discover the latest research here.